4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-052671
Chairman and CEO bought 9,750 shares at an average $0.99 ($9,685)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-09-29 | Purchase | +3,250 | $0.98 | $3,185 | 10,691,996 | D |
| Niihara Yutaka Chairman and CEO | 2020-10-01 | Purchase | +6,500 | $1.00 | $6,500 | 10,698,496 | D |
| Open-market purchases · 9,750 sh · avg $0.99 · $9,685 | |||||||
Loading xslF345X03/doc4.xml…